Updated on 16 July 2014
The company said in a statement that, "In trials, the software has been shown to be almost twice as effective as traditional dosing methods."
Dr Robert McLeay, co-founder and technical director, DoseMe said that funds from this and future capital raisings will be put towards scaling up the company's operations. "We now have hospitals, pharmacies and individual doctors using the system in Queensland, Western Australia and Victoria. Future investment rounds will be used to help us scale our business by expanding the product to new medications and also to roll out DoseMe to further international markets," he added.